ArticleJournal of pharmacology & pharmacotherapeutics2011
Adverse drug reactions of nonsteroidal anti-inflammatory drugs in orthopedic patients.
Article in Journal of pharmacology & pharmacotherapeutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Assessment of a taping method combined with manual therapy as a treatment of non-specific chronic low back pain - a randomized controlled trial.BMC musculoskeletal disorders · 2021Trial
- Trial
- Facing the Side Effects: Patient-Reported Adverse Outcomes of NSAIDs for Chronic Pain Management in North India.Journal of patient experience · 2026Article
- Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study.BMJ open · 2021Article
- Duloxetine for the Treatment of Chronic Low Back Pain: A Systematic Review of Randomized Placebo-Controlled Trials.Cureus · 2021Review
- Comparison of Two Different Analgesic Prescription Strategies and Healthcare Systems: Slovenia vs. the Netherlands.Frontiers in pain research (Lausanne, Switzerland) · 2021Article
- Toxicity of diclofenac sodium salt in Yucatan minipigsToxicology reports · 2021Article
- Causes and consequences of the opioid epidemic in the Netherlands: a population-based cohort study.Scientific reports · 2020Article
- Use of ibuprofen sustained release for treating osteoarthritic pain: findings from 15 general medical practices in Egypt.Open access rheumatology : research and reviews · 2014Article
- Days lost due to disability of diclofenac-induced adverse drug reactions.Pharmacy practice · 2012Article
- Adverse drug reactions of nonsteroidal anti-inflammatory drugs.Journal of pharmacology & pharmacotherapeutics · 2011Article
- Evaluation of adverse drug reactions in HIV positive patients in a tertiary care hospital.Perspectives in clinical researchArticle
- Evaluation of a curcumin-containing mucoadhesive film for periodontal postsurgical pain control.Journal of Indian Society of PeriodontologyArticle
- Retrospective Assessment of the Reporting of Adverse Drug Reactions in a Malaysian Clinical Training Center: A Short Communication.Journal of pharmacy & bioallied sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo identify the ADRs due to NSAIDs and to know how to monitor the drug's effect. MATERIALS AND
methodsA descriptive study was undertaken in the Orthopedic Outpatients Department of a tertiary care teaching hospital. Hundred patients were enrolled in this study to observe the risk of adverse drug reactions (ADRs) due to NSAIDs. All the ADRs were further analyzed in relation to age and sex, type of drug and its pattern. Probability scale was used for the causality assessment of the ADRs.
results26% of the 100 patients developed ADR due to NSAIDs. There was not much of a difference in the number of the ADRs in relation to the gender. Diclofenac was the highest prescribed drug (65 patients), followed by paracetamol (12), nimesulide (10), ibuprofen (6), piroxicam (5) and Etoricoxib (2). Diclofenac accounted for the maximum number (73%) of ADRs, followed by nimesulide (16%), paracetamol (7%), and Etoricoxib (4%).
conclusionPharmacovigilance improves recognition of ADRs by the medical students. It allows the treating physician to identify the ADR associated with drugs, in particular, with the ones considered relatively safe and with those commonly prescribed by the medical and non-health professionals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.